2022
Gurugram (India)
Seed
Curelo operates in the healthtech sector as a digital aggregator platform for diagnostic labs, serving urban and semi-urban markets provides a one-stop solution for booking lab tests, home sample collection, and digital report delivery, connecting patients with over 1,500 certified labs and offering 5,000+ diagnostic tests. Curelo’s tech-driven, asset-light model enables patients to book tests from any lab of their choice, with free home sample collection and rapid turnaround. The company’s CURELO FLASH service—India’s first 10-minute doorstep blood sample collection—sets a new benchmark for convenience and speed in diagnostics.
Lab Test Aggregation Platform: Digital marketplace allowing users to book 3,000+ tests from 1,500+ labs, with transparent pricing and lab selection.
Home Sample Collection: Free, certified phlebotomist-led sample collection at the patient’s preferred time and location, available 24/7 in select cities.
CURELO FLASH: 10-minute doorstep blood sample collection service, currently live in Gurugram and expanding to other cities—an industry-first for speed and convenience.
Digital Health App: Enables test booking, prescription uploads, report management, and access to health and wellness content.
No-Cost EMI for Lab Tests: First in India to offer zero-interest EMI options on all lab tests, reducing financial barriers for patients.
Wellness Packages & Preventive Health: Curated health checkup packages and preventive screening panels, with digital delivery of results
Commission-Based Revenue: Core revenue from commissions on each test booked through the platform, paid by partner labs.
Service Fees: Additional income from value-added services such as CURELO FLASH, wellness packages, and digital health subscriptions.
B2B Partnerships: Revenue from onboarding and standardizing unorganized labs, as well as providing technology integration and operational support
Diagnostic Lab Network: Over 1,500 partner labs nationwide, including both standalone and hospital-based facilities, ensuring broad test availability and geographic reach.
Strategic Investors & Ambassadors: IIMA Ventures (IIM Ahmedabad’s fund), Shreyas Iyer (cricketer and brand ambassador), Tarun Katial (Zee5 co-founder), and US family offices—providing capital, strategic guidance and brand visibility. Dr. Arpit Jayswal (founder and CEO) brings deep healthcare and diagnostics expertise.
Technology & Logistics Partners: Collaborations for logistics, IoT, and digital health integration to ensure sample integrity and rapid turnaround
Geographic Expansion: Aggressively scaling CURELO FLASH and home collection services to new cities, targeting a 300% increase in patient base by 2025 (reflecting recent market trends).
Product Innovation: Expanding into radiology and blood bank aggregation, and developing new at-home healthcare services tailored to diverse patient needs.
Technology Investment: Continued enhancement of the digital platform, AI-driven patient engagement, and operational automation to improve user experience and efficiency.
Regulatory Uncertainty: Evolving healthcare and diagnostics regulations could impact compliance costs and operational flexibility, especially as Curelo scales national.
$2.3 Million
2
$2.2 Million, Seed
as of March 15, 2024
$10.4 Million
as of April 5, 2025
4.7
as of April 5, 2025
IIMA Ventures
108
Orange health
N/A
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
March 15, 2024 | Seed | $2.2 Million | - | $714 K | - | IIMA Ventures |
January 5, 2023 | Seed | $100 K | $8 Million | - | - | IIMA Ventures |
January 17, 2025
April 4, 2024
October 11, 2023